EXELA PHARMA SCIENCES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at EXELA PHARMA SCIENCES is $90,000, based on 21 certified filings from FY 2021 to FY 2025. This is 25% lower than the national H-1B median salary of $120,000. Compensation at EXELA PHARMA SCIENCES reflects their market positioning, with entry-level roles starting around $80,000 and senior positions reaching $100,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at EXELA PHARMA SCIENCES range from $73,000 at the 10th percentile to $100,000 at the 90th percentile, showing a $27,000 spread across experience levels and roles. The 25th percentile is $80,000 and the 75th percentile is $100,000.

Yes, EXELA PHARMA SCIENCES actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 23 H-1B labor condition applications from FY 2021 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 21 certified applications and a 0% denial rate, EXELA PHARMA SCIENCES maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), EXELA PHARMA SCIENCES filed 4 H-1B applications, with 4 certified and 0 denied. Over 5 years of data, EXELA PHARMA SCIENCES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

EXELA PHARMA SCIENCES's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 23 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating EXELA PHARMA SCIENCES as a potential H-1B sponsor.

This is an excellent approval rate, indicating EXELA PHARMA SCIENCES has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

EXELA PHARMA SCIENCES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 21 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles EXELA PHARMA SCIENCES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at EXELA PHARMA SCIENCES:

The most frequently sponsored role is Financial Analyst with 2 filings at a median salary of $100,000. This is followed by Analytical & Research Validation Chemist (Sr. Supervisory) (2 filings) and Electrical Engineer.

EXELA PHARMA SCIENCES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where EXELA PHARMA SCIENCES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top EXELA PHARMA SCIENCES H-1B locations:

The largest H-1B hub for EXELA PHARMA SCIENCES is Lenoir, NC with 21 filings at a median salary of $90,000.

EXELA PHARMA SCIENCES's median H-1B salary has increased by +4% from FY 2021 ($86,466) to FY 2025 ($90,000). Tracking salary trends over time reveals how EXELA PHARMA SCIENCES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at EXELA PHARMA SCIENCES.

Year-by-year breakdown:

• FY 2021: $86,466 (3 certified)
• FY 2022: $87,000 (3 certified)
• FY 2023: $85,000 (4 certified)
• FY 2024: $100,000 (7 certified)
• FY 2025: $90,000 (4 certified)

EXELA PHARMA SCIENCES has maintained steady salary growth for H-1B positions over this period.

EXELA PHARMA SCIENCES primarily files H-1B applications at Wage Level IV, accounting for 48% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making EXELA PHARMA SCIENCES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 95% of positions at Level II or higher, EXELA PHARMA SCIENCES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

EXELA PHARMA SCIENCES's median H-1B salary of $90,000 is 25% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating EXELA PHARMA SCIENCES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare EXELA PHARMA SCIENCES's offerings with similar companies in your field for a more accurate assessment.

EXELA PHARMA SCIENCES's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. EXELA PHARMA SCIENCES's higher proportion of Level III-IV positions (71%) may benefit from wage-based lottery prioritization.

With 21 certified filings, EXELA PHARMA SCIENCES invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.